An2 Therapeutics, INC. (ANTX) — SC 13G/A Filings
All SC 13G/A filings from An2 Therapeutics, INC.. Browse 10 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (10)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 13, 2024
- SC 13G/A Filing — Aug 28, 2024
- SC 13G/A Filing — Aug 14, 2024
- SC 13G/A Filing — Aug 13, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Janus Henderson Cuts AN2 Therapeutics Stake to Zero Voting Shares
— Feb 12, 2024 Risk: medium
Janus Henderson Group plc, a global investment manager, filed an amended SC 13G/A on February 12, 2024, indicating a change in their beneficial ownership of AN2 -
Adjuvant Capital Reduces AN2 Therapeutics Stake, Files SC 13G/A
— Feb 9, 2024 Risk: medium
Adjuvant Global Health Technology Fund, L.P. filed an amended SC 13G/A on February 9, 2024, indicating a change in their ownership of AN2 Therapeutics, Inc. com
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX